Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury

Observations in rats

C. R. Scanzello, G. Hatzidimitriou, A. L. Martello, J. L. Katz, George Ricaurte

Research output: Contribution to journalArticle

Abstract

(±)3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin (5-HT) neurons in animals. In monkeys, the damage appears to be permanent. By contrast, in rats there is indication that neuronal recovery takes place, although there is question as to whether the recovery is sustained. The purpose of the present study was to examine the fate of 5-HT neurons in MDMA-treated rats, and to compare findings in the rat with those in the monkey. Rats were treated with MDMA (10 mg/kg i.p.) every 2 hr for a total dose of 40 mg/kg. Two, 8, 16, 32 and 52 weeks later, groups (n = 8) of MDMA-treated rats, along with age-matched controls (n = 8), were analyzed for regional brain 5-HT, 5-hydroxyindoleacetic acid and [3]paroxetine-labeled 5-HT uptake sites. Two weeks after MDMA, 5-HT neuronal markers were reduced markedly. Reductions ranged from 42 to 82% depending on brain region. By 16 weeks, there was evidence of recovery in some brain regions (e.g., hypothalamus and striatum) and by 32 weeks, recovery was nearly complete in most brain regions examined. One year after MDMA, recovery was still evident in all brain regions evaluated, although closer inspection of the group data revealed that whereas most MDMA-treated rats recovered, some did not. These few animals had severe and enduring serotonergic deficits in multiple brain regions. Morphologic immunocytochemical studies yielded results which corroborated the neurochemical findings. Together, these observations suggest that 5-HT neurons in most (but not all) rats recover from MDMA injury, and that in those rats which recover, recovery is maintained for at least 1 year after MDMA treatment. Further studies are needed to determine if recovery is sustained for longer than 1 year, and to define the factors which govern 5-HT neuronal recovery after MDMA injury.

Original languageEnglish (US)
Pages (from-to)1484-1491
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume264
Issue number3
StatePublished - 1993

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Methamphetamine
Serotonin
Wounds and Injuries
Brain
Street Drugs
Neurons
Haplorhini
Paroxetine
Hydroxyindoleacetic Acid
Hypothalamus

ASJC Scopus subject areas

  • Pharmacology

Cite this

Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury : Observations in rats. / Scanzello, C. R.; Hatzidimitriou, G.; Martello, A. L.; Katz, J. L.; Ricaurte, George.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 264, No. 3, 1993, p. 1484-1491.

Research output: Contribution to journalArticle

Scanzello, C. R. ; Hatzidimitriou, G. ; Martello, A. L. ; Katz, J. L. ; Ricaurte, George. / Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury : Observations in rats. In: Journal of Pharmacology and Experimental Therapeutics. 1993 ; Vol. 264, No. 3. pp. 1484-1491.
@article{60c0a5d5b8ab4721868a5af6e9d07ae5,
title = "Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury: Observations in rats",
abstract = "(±)3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin (5-HT) neurons in animals. In monkeys, the damage appears to be permanent. By contrast, in rats there is indication that neuronal recovery takes place, although there is question as to whether the recovery is sustained. The purpose of the present study was to examine the fate of 5-HT neurons in MDMA-treated rats, and to compare findings in the rat with those in the monkey. Rats were treated with MDMA (10 mg/kg i.p.) every 2 hr for a total dose of 40 mg/kg. Two, 8, 16, 32 and 52 weeks later, groups (n = 8) of MDMA-treated rats, along with age-matched controls (n = 8), were analyzed for regional brain 5-HT, 5-hydroxyindoleacetic acid and [3]paroxetine-labeled 5-HT uptake sites. Two weeks after MDMA, 5-HT neuronal markers were reduced markedly. Reductions ranged from 42 to 82{\%} depending on brain region. By 16 weeks, there was evidence of recovery in some brain regions (e.g., hypothalamus and striatum) and by 32 weeks, recovery was nearly complete in most brain regions examined. One year after MDMA, recovery was still evident in all brain regions evaluated, although closer inspection of the group data revealed that whereas most MDMA-treated rats recovered, some did not. These few animals had severe and enduring serotonergic deficits in multiple brain regions. Morphologic immunocytochemical studies yielded results which corroborated the neurochemical findings. Together, these observations suggest that 5-HT neurons in most (but not all) rats recover from MDMA injury, and that in those rats which recover, recovery is maintained for at least 1 year after MDMA treatment. Further studies are needed to determine if recovery is sustained for longer than 1 year, and to define the factors which govern 5-HT neuronal recovery after MDMA injury.",
author = "Scanzello, {C. R.} and G. Hatzidimitriou and Martello, {A. L.} and Katz, {J. L.} and George Ricaurte",
year = "1993",
language = "English (US)",
volume = "264",
pages = "1484--1491",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury

T2 - Observations in rats

AU - Scanzello, C. R.

AU - Hatzidimitriou, G.

AU - Martello, A. L.

AU - Katz, J. L.

AU - Ricaurte, George

PY - 1993

Y1 - 1993

N2 - (±)3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin (5-HT) neurons in animals. In monkeys, the damage appears to be permanent. By contrast, in rats there is indication that neuronal recovery takes place, although there is question as to whether the recovery is sustained. The purpose of the present study was to examine the fate of 5-HT neurons in MDMA-treated rats, and to compare findings in the rat with those in the monkey. Rats were treated with MDMA (10 mg/kg i.p.) every 2 hr for a total dose of 40 mg/kg. Two, 8, 16, 32 and 52 weeks later, groups (n = 8) of MDMA-treated rats, along with age-matched controls (n = 8), were analyzed for regional brain 5-HT, 5-hydroxyindoleacetic acid and [3]paroxetine-labeled 5-HT uptake sites. Two weeks after MDMA, 5-HT neuronal markers were reduced markedly. Reductions ranged from 42 to 82% depending on brain region. By 16 weeks, there was evidence of recovery in some brain regions (e.g., hypothalamus and striatum) and by 32 weeks, recovery was nearly complete in most brain regions examined. One year after MDMA, recovery was still evident in all brain regions evaluated, although closer inspection of the group data revealed that whereas most MDMA-treated rats recovered, some did not. These few animals had severe and enduring serotonergic deficits in multiple brain regions. Morphologic immunocytochemical studies yielded results which corroborated the neurochemical findings. Together, these observations suggest that 5-HT neurons in most (but not all) rats recover from MDMA injury, and that in those rats which recover, recovery is maintained for at least 1 year after MDMA treatment. Further studies are needed to determine if recovery is sustained for longer than 1 year, and to define the factors which govern 5-HT neuronal recovery after MDMA injury.

AB - (±)3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin (5-HT) neurons in animals. In monkeys, the damage appears to be permanent. By contrast, in rats there is indication that neuronal recovery takes place, although there is question as to whether the recovery is sustained. The purpose of the present study was to examine the fate of 5-HT neurons in MDMA-treated rats, and to compare findings in the rat with those in the monkey. Rats were treated with MDMA (10 mg/kg i.p.) every 2 hr for a total dose of 40 mg/kg. Two, 8, 16, 32 and 52 weeks later, groups (n = 8) of MDMA-treated rats, along with age-matched controls (n = 8), were analyzed for regional brain 5-HT, 5-hydroxyindoleacetic acid and [3]paroxetine-labeled 5-HT uptake sites. Two weeks after MDMA, 5-HT neuronal markers were reduced markedly. Reductions ranged from 42 to 82% depending on brain region. By 16 weeks, there was evidence of recovery in some brain regions (e.g., hypothalamus and striatum) and by 32 weeks, recovery was nearly complete in most brain regions examined. One year after MDMA, recovery was still evident in all brain regions evaluated, although closer inspection of the group data revealed that whereas most MDMA-treated rats recovered, some did not. These few animals had severe and enduring serotonergic deficits in multiple brain regions. Morphologic immunocytochemical studies yielded results which corroborated the neurochemical findings. Together, these observations suggest that 5-HT neurons in most (but not all) rats recover from MDMA injury, and that in those rats which recover, recovery is maintained for at least 1 year after MDMA treatment. Further studies are needed to determine if recovery is sustained for longer than 1 year, and to define the factors which govern 5-HT neuronal recovery after MDMA injury.

UR - http://www.scopus.com/inward/record.url?scp=0027339403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027339403&partnerID=8YFLogxK

M3 - Article

VL - 264

SP - 1484

EP - 1491

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -